Genetic ‘biobank’ version of Yellow Card scheme to be piloted by drugs regulator Genetic data and samples from patients who have experienced adverse side effects to medicines will be stored in the biobank, which will be used to determine whether the reaction was the result of a genetic trait.…
PJ view: a pharmacogenomic revolution is gathering pace There has been rapid progress in the use of pharmacogenomics in patient care over the past 18 months — and it appears to be just the start.…
NICE to recommend genetic testing before prescribing clopidogrel The National Institute for Health and Care Excellence has said genetic testing before initiating clopidogrel is a cost-effective use of NHS resources for patients at risk of stroke.…
Pharmacogenomic testing pilot to start in general practice from June 2023 The pilot will test patients when they start a new statin, certain antidepressants or proton pump inhibitors to ensure they are on the right medication and not at risk of side effects.…
Newborn genome screening: a step too far? A project to screen the genomes of 100,000 babies for rare diseases is set to begin recruiting in 2023, but it will face ethical and societal challenges.…
Pharmacists should be able to refer patients to NHS genomics services, says Royal Pharmaceutical Society In the Society's consultation response, Thorrun Govind said there needs to be an explanation of how pharmacy staff can enrich and complement the NHS Clinical Genomics Service.…
Clinical impact of CFTR modulator therapy roll-out An overview of the essential role a specialist cystic fibrosis pharmacist has in the optimisation of CFTR modulator combinations and a closer look at real-world clinical outcomes.…
How we set up the UK’s first clopidogrel genomics testing system Specialist clinical pharmacist Alex Matos explains how he has been implementing pharmacogenomics in daily use on the acute stroke ward.…
Safety review launched into anti-epileptic medicine topiramate over fears of harm to unborn children The review was prompted by study results that showed there was a two- to four-fold increased risk of developmental disorders or learning difficulties in children exposed to topiramate before birth.…
Pharmacogenomic testing may aid antidepressant prescribing, study results show Researchers found that patients with major depressive disorder whose treatment was guided by genetic testing were more likely to receive an antidepressant with no drug–gene interaction.…
